Brief: Akoya Reports Record Revenue In The First Quarter Of 2023 And Reiterates Full Year 2023 Revenue Guidance
08/05/2023 23:32
May 8 (Reuters) - Akoya Biosciences Inc AKYA.O :
* AKOYA REPORTS RECORD REVENUE IN THE FIRST QUARTER OF 2023
AND
REITERATES FULL YEAR 2023 REVENUE GUIDANCE
* REITERATING FY 2023 REVENUE GUIDANCE RANGE OF $95-98
MILLION
* Q1 EARNINGS PER SHARE VIEW $-0.48, REVENUE VIEW $20.3
MILLION --
REFINITIV IBES DATA
* FY2023 REVENUE VIEW $95.9 MILLION -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX5g0jJx
Further company coverage: AKYA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Akoya Biosciences
See all newsBrief: Akoya Biosciences Inc - On May 20, Receives Unsolicited Acquisition Proposal At $1.40 Per Share From A Third Party- SEC Filing
Akoya Biosciences Inc reports results for the quarter ended March 31 - Earnings Summary
Brief: Akoya Biosciences Q1 Gross Margin 59.3%
Akoya Biosciences Inc expected to post a loss of 20 cents a share - Earnings Preview
Leerink Partners downgrades Quanterix to 'market perform' on Akoya deal risks